WEE1 and cancer: Wee1 blockade, an emerging anticancer therapy among a range of cancer types [9–11], can abrogate the G2/M checkpoint and force cancer cells with unrepaired DNA lesions to enter into unscheduled mitosis and undergo DNA damage-mediated cell death, namely, mitotic catastrophe [4, 12].